Dongin (Donoven) Kim, Ph.D.

Assistant Professor

Pharmaceutical Sciences

Phone (405) 271-6593 x 47473

Alt Phone (801) 574-6823 (cell)

Office College of Pharmacy, CPB 317

Email dongin-kim@ouhsc.edu


Publications & Presentations

1 2 3 4 > >>
    1. Kim D. A Benzenesulfonamide-based mitochondrial uncoupler induces endoplasmic reticulum stress and immunogenic cell death in epithelial ovarian cancer . Molecular Cancer Theraeputics. 2021; 21 : 2398-2409

    2. Kim D. A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive Mice . Pharmaceutics. 2021; 14 : 84

    3. Kim D. pH-responsive Nanomedicine for Image-guided Drug Delivery . Pan Stanford Publishing. 2021

    4. Kim D. Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin. Nature Biomedical Engineering. In Press; 5 : 983-997

    5. Kim Y, Youn Y S, Oh K T, Kim D, Lee E S. Tumor-Targeting Liposomes with Transient Holes Allowing Intact Rituximab Internally. Biomacromolecules. 2020

1 2 3 4 > >>



Grants

    1. Lymphatics and lymphangiogenesis in kidney function and inflammation. NIH. Start Date: 2019. End Date: 2024.

    2. Role of Renal Lymphatics in Blood Pressure Regulation. NIH. Start Date: 2018. End Date: 2023.

    3. Engineering Exosome for Ovarian Cancer Targeting Therapy. NIH. Start Date: 2021. End Date: 2023.

    4. Developing RNAi-based control method targeting Mormon cricket. Misc Federal. Start Date: 2020. End Date: 2021.




Awards and Honors


no results

Education

                                                                                            1.  Degree: Ph D. University of Utah. Date: 2009.  

                                                                                            2.  Degree: MS. University of Florida. Date: 2002.  

                                                                                            3.  Degree: BS. Ajou University. Date: 1999.